Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1859 Drostanolone Propionate
Inhibitor of the growth of estrogen receptor-presenting breast cancers
More description
DCC1858 Dropropizine
Oral non-opioid anti-tussive agent for treatment of cough
More description
DCC1857 Dri-c91005
Novel inhibitor of the interaction of hACE2 with the spike proteins of SARS-CoV-2 as well as SARS-CoV
More description
DCC1856 Dri-c23041
Novel inhibitor of the interaction of hACE2 with the spike proteins of SARS-CoV-2 as well as SARS-CoV
More description
DCC1855 Dp-v-4
Novel Dual PROTAC for Simultaneous Degradation of EGFR and PARP
More description
DCC1854 D-propargylglycine
Click chemistry tool molecule in probing peptidoglycan (PG)
More description
DCC1853 Dpre1-in-377790
Novel DprE1 inhibitor, killing M. tuberculosis
More description
DCC1852 Dppe Hydrochloride
Substrate of CYP3A and inhibitor of P-glycoprotein
More description
DCC1851 Dpp8/9-in-8j
Novel selective DPP8/9 inhibitor, blocking AML progression in vivo
More description
DCC1850 Dpp7-in-5385
Novel inhibitor of dipeptidyl peptidase 7 (DPP7)
More description
DCC1849 Dpi-287
Novel highly selective agonist for the δ-opioid receptor, producing less convulsions than most drugs from this family and having antidepressant-like effects
More description
DCC1848 Dpf-p10
First Potent Small Molecule Ligand for MALAT1
More description
DCC1847 Dp-c-1
Novel Dual PROTAC for Simultaneous Degradation of EGFR and PARP
More description
DCC1846 Dpbx-l-dopa
Novel boron-containing dopa-derivative, acting as a bladder relaxant through non-catecholamine receptors
More description
DCC1845 Dpb163-ae
Novel 2-aminoethyl diphenylborinate (2-APB) analogue, inducing a profound activation of SOCE in DT40 cells, albeit at low concentrations (10 nM), blocking the melatonin-induced [Ca ] cyt increase and SOCE in P. falciparum.
More description
DCC1844 Dpa-154
Novel effective and selective inhibitor of E. coli topoisomerase I
More description
DCC1843 Dp-326
Novel antibacterial with activity against the Gram-negative bacteria associated with nosocomial infections
More description
DCC1842 Dov51892
Agonist of GABAA receptors α15 subunits
More description
DCC1841 Dothiepin Hydrochloride
Tricyclic antidepressant (TCA), acting as a serotonin–norepinephrine reuptake inhibitor (SNRI) and also having other activities including antihistamine, antiadrenergic, antiserotonergic, anticholinergic, and sodium channel-blocking effects
More description
DCC1840 Doramectin
Anthelmintic, for the treatment of parasites such as gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites in cattle
More description
DCC1839 Dora 42
Dual orexin receptor antagonist (OX1R and OX2R antagonist or DORA)
More description
DCC1838 Doot-2d
Selective MAO-B inhibitor
More description
DCC1836 Do-601
Analeptic agent, stimulating central nervous system; Anti-barbiturate-overdose
More description
DCC1835 Dndi-0690
Novel antitubercular and antiparasitic agent, possessing excellent in vitro activity against both L. donovani and Leishmania infantum as well as displaying a better safety profile
More description
DCC1834 Dnac-1
Novel potentiator of β-lactam activity against Gram positive and Gram negative pathogens
More description
DCC1833 Dna Primase Inhibitor-13
Novel DNA primase inhibitor
More description
DCC1832 Dna Primase Inhibitor-1
Novel DNA primase inhibitor
More description
DCC1831 Dmxb-a
Novel,orally active and selective alpha-7 nicotinic acetylcholine (nACh) receptor
More description
DCC1830 Dmt-dalda
Potent and highly selective µ opioid agonist
More description
DCC1829 Dmocptl
Novel inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X